Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules" does not refer to a single molecular target but rather describes the complex interaction network within the tumor microenvironment (TME) or a regenerative tissue niche. This system involves a diverse array of cells, including T lymphocytes, macrophages, dendritic cells, fibroblasts, and endothelial cells, which coordinate biological processes through secreted paracrine signals (e.g., cytokines, chemokines) and direct cell-to-cell adhesion (e.g., integrins, selectins). In pathological states like cancer, this network is often hijacked to create an immunosuppressive environment that protects malignant cells from immune surveillance and promotes metastasis. Therapeutic interventions targeting this system, such as mesenchymal stromal cell (MSC) therapies or multi-target checkpoint inhibitors, aim to disrupt these suppressive interactions and restore homeostatic or anti-tumor immune responses. Because it encompasses a broad range of cellular players and signaling pathways, it represents a systemic therapeutic focus rather than a discrete molecular entity.
Modulation of the cellular network through the secretion of cytokines and chemokines (paracrine factors) and direct cell-to-cell contact via adhesion molecules to alter the local immune landscape.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple immune and stromal cell types via paracrine factors and surface adhesion molecules.